Long Term Vaccine Study

---------- Forwarded message --------- From: John Ames Birch <amesbirch403@gmail.com> Date: Thu., Sep. 16, 2021, 5:29 p.m. Subject: Long Term Vaccine Study (Opinion) To: <justin.trudeau@parl.gc.ca>, <chrystia.freeland@parl.gc.ca>, <dujarric@un.org>, <antonio.ferrari@un.org>, <anthony.rota.c1@parl.gc.ca>, <assistance@liberal.ca>, <actso@naacpnet.org>, <aclupreferences@aclu.org>, <ASH@hhs.gov>, <eurohealthycities@who.int>, <ecampaign@gop.com>, <carolyn.bennett@parl.gc.ca>, <calgary@globalnews.ca>, <chinaembpress_us@mfa.gov.cn>, <cnn.feedback@cnn.com>, <dir_enq@cso.gov.hk>, David Hulen <dhulen@adn.com>, <edmonton@globalnews.ca>, <eonline@bellmedia.ca>, <editor@japantoday.com>, <egypt@ad.gov.eg>, <Francois-Philippe.Champagne@parl.gc.ca>, <GlobalBarrie@globalnews.ca>, <haveyoursay@bbc.co.uk>, <info@ccla.org>, <jagmeet.singh@parl.gc.ca>, <media@aclu.com>, <msnbctvinfo@nbcuni.com>, <newstips@globaltv.com>, <newschannel@ctv.ca>, <newsonline@ctv.ca>, <osd.pentagonpressbadges@mail.mil>, <premier@gov.ab.ca>, <premier@gov.bc.ca>, <reportit@kxan.com>, <tips@thetexan.news>, <tonews@cbc.ca>, <ViewerContactToronto@globalnews.ca>, <ViewerContactCalgary@globalnews.ca>, <washingtonbureau@naacpnet.org>, <w5@ctv.ca>, <weekend@cbsnews.com>

Hey Everyone, I was thinking about the vaccines and the viruses ability to mutate into different strains. I was therefore thinking that we complete a study of vaccine recipients and their status to keep up to date on possible new variants as well as each vaccine's efficacy in use. There might already be studies in place but perhaps we can unify our findings and work together to ensure that we are always ready if a new variant mutates. Long term findings on this virus and the vaccine efficacy will help us combat any future pandemics. As such if we can review this with the medical community it would be greatly appreciated. Stay Safe, Stay Sanitized and Stay Supportive, John Ames Birch @johneames2